Anti-Malaria drugs have shown promise in treating cancer, and now researchers know why

(University of Pennsylvania School of Medicine) Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers from the Abramson Cancer Center of the University of Pennsylvania say they have identified that target -- an enzyme called PPT1.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news